Macitentan real-world experience in elderly patients over 75 years with pulmonary arterial hypertension (PAH)
N. Kim (La Jolla, United States), R. Channick (Los Angeles, United States), K. Chin (Dallas, United States), L. Mitchell (Allschwil, Switzerland), S. Turricchia (Allschwil, Switzerland), R. Ong (Allschwil, Switzerland), V. Mclaughlin (Ann Arbor, United States)
Source: International Congress 2022 – Treatment of pulmonary arterial hypertension
Session: Treatment of pulmonary arterial hypertension
Session type: Thematic Poster
Number: 2675
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kim (La Jolla, United States), R. Channick (Los Angeles, United States), K. Chin (Dallas, United States), L. Mitchell (Allschwil, Switzerland), S. Turricchia (Allschwil, Switzerland), R. Ong (Allschwil, Switzerland), V. Mclaughlin (Ann Arbor, United States). Macitentan real-world experience in elderly patients over 75 years with pulmonary arterial hypertension (PAH). 2675
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|